KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Accumulated Expenses (2016 - 2025)

Eli Lilly's Other Accumulated Expenses history spans 17 years, with the latest figure at $8.5 billion for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 32.2% year-over-year to $8.5 billion; the TTM value through Dec 2025 reached $8.5 billion, up 32.2%, while the annual FY2025 figure was $8.5 billion, 32.2% up from the prior year.
  • Other Accumulated Expenses reached $8.5 billion in Q4 2025 per LLY's latest filing, up from $5.2 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $8.5 billion in Q4 2025 to a low of $2.0 billion in Q3 2022.
  • Average Other Accumulated Expenses over 5 years is $3.7 billion, with a median of $2.9 billion recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: fell 23.67% in 2022, then surged 115.84% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $3.0 billion in 2021, then fell by 6.01% to $2.8 billion in 2022, then rose by 15.32% to $3.3 billion in 2023, then skyrocketed by 94.95% to $6.4 billion in 2024, then surged by 32.2% to $8.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Other Accumulated Expenses are $8.5 billion (Q4 2025), $5.2 billion (Q3 2025), and $5.1 billion (Q2 2025).